Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Holders of 5% or more of EGRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eagle Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 38.08%4.95M shares | 0.00 ppfrom 38.08% | Feb 19, 20252 filings | Aug 14, 2025 | SEC |
| Union Square Park Capital Management, LLC | 13G/A | 11.44%1.49M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Nantahala Capital Partners Limited Partnership | 13G | 6.24%810.6K shares | New | Feb 19, 20251 filing | Feb 19, 2025 | SEC |
| J. Goldman & Co LP | 13G | 5.10%667.1K shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Eagle Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20258:08 PM ET | J. Goldman & Co LPand 2 others | 13G | 5.10%667.1K shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20254:42 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 38.08%4.95M shares | 0.00 ppfrom 38.08% | Jun 30, 2025 | SEC |
| Feb 19, 20254:32 PM ET | Nantahala Capital Partners Limited Partnershipand 2 others | 13G | 6.24%810.6K shares | New | Feb 16, 2025 | SEC |
| Feb 19, 20254:32 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 38.08%4.95M shares | – | Feb 16, 2025 | SEC |
| Feb 14, 20259:01 AM ET | Union Square Park Capital Management, LLCand 3 others | 13G/A | 11.44%1.49M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 2022 | Tarriff Scott | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Park West Asset Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 27, 202211:00 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20223:03 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Tarriff Scott | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Park West Asset Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | State Street Corp | 13GOld format | – | New | – | SEC |
| Jan 26, 20212:22 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Eagle Pharmaceuticals, Inc. shares.
No Form 144 notices for Eagle Pharmaceuticals, Inc. are on file.